Cary Street Partners Investment Advisory’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-121	Closed	-$13.6K	–	1387
2023 Q3	$13.6K	Hold	121	–	–	﹤0.01%	1217
2023 Q2	$11.4K	Buy	121 +12	+11%	+$1.13K	﹤0.01%	1205
2023 Q1	$11K	Hold	109	–	–	﹤0.01%	1122
2022 Q4	$13K	Buy	+109	New	+$13K	﹤0.01%	1077